Menu
Fechar
HRS4R
Vull donar

Pedraza S, Silva Y, Mendez J, Inaraja L, Vera J, Serena J, Dávalos A

Comparison of preperfusion and postperfusion magnetic resonance angiography in acute stroke.

Stroke, 2004, 35, 2105-2110 dx.doi.org/10.1161/01.STR.0000136950.63209.49

Menendez JA, Colomer R, Lupu R

Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells.

ONCOLOGY REPORTS, 2004, 12, 411-422

Fernández-Real JM, López-Bermejo A, Broch M, Vendrell J, Richart C, Ricart W

Circulating soluble CD14 monocyte receptor is associated with increased alanine aminotransferase

CLINICAL CHEMISTRY, 2004, 50, 1456-1458 dx.doi.org/10.1373/clinchem.2003.030015

Menendez JA, Vellon L, Mehmi I, Oza BP, Ropero S, Colomer R, Lupu R

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101, 10715-10720 dx.doi.org/10.1073/pnas.0403390101

López-Pousa S, Vilalta-Franch J, Llinàs-Regla J, Garre-Olmo J, Román GC

Incidence of dementia in a rural community in Spain: the Girona cohort study.

Neuroepidemiology, 2004, 23, 170-177 dx.doi.org/10.1159/000078502

Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Dávalos A

Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.

Stroke, 2004, 35, 1671-1676 dx.doi.org/10.1161/01.STR.0000131656.47979.39

Ropero S, Menéndez JA, Vázquez-Martín A, Montero S, Cortés-Funes H, Colomer R

Trastuzumab plus tamoxifen: anti-proliferative and molecular interactions in breast carcinoma.

BREAST CANCER RESEARCH AND TREATMENT, 2004, 86, 125-137 dx.doi.org/10.1023/B:BREA.0000032981.20384.c6

Menendez JA, Oza BP, Atlas E, Verma VA, Mehmi I, Lupu R

Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.

Oncogene, 2004, 23, 4945-4958 dx.doi.org/10.1038/sj.onc.1207476

Menendez JA, Ropero S, Mehmi I, Atlas E, Colomer R, Lupu R

Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.

INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24, 1369-1383

López-Pousa S, Garre-Olmo J, Turon-Estrada A, Hernández F, Expósito I, Lozano-Gallego M, Hernández-Ferrándiz M, Gelada-Batlle E, Pericot-Nierga I, Vilalta-Franch J

Análisis de los costes de la enfermedad de Alzheimer en función del deterioro cognitivo y funcional.

MEDICINA CLINICA, 2004, 122, 767-772 dx.doi.org/10.1157/13062665

Menendez JA, Colomer R, Lupu R

Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) is a selective estrogen-response modulator in human breast cancer cells: gamma-linolenic acid antagonizes estrogen receptor-dependent transcriptional activity, transcriptionally represses estrogen receptor expression and synergistically enhances tamoxifen and ICI 182,780 (Faslodex) efficacy in human breast cancer cells.

INTERNATIONAL JOURNAL OF CANCER, 2004, 109, 949-954 dx.doi.org/10.1002/ijc.20096

Ibañez J, Arikan F, Pedraza S, Sánchez E, Poca MA, Rodriguez D, Rubio E

Reliability of clinical guidelines in the detection of patients at risk following mild head injury: results of a prospective study.

JOURNAL OF NEUROSURGERY, 2004, 100, 825-834 dx.doi.org/10.3171/jns.2004.100.5.0825

Recasens M, Ricart W, Fernández-Real JM

Obesidad e inflamación.

Revista De Medicina De La Universidad De Navarra, 2004, 48, 49-54

Menendez JA, Lupu R, Colomer R

Inhibition of tumor-associated fatty acid synthase hyperactivity induces synergistic chemosensitization of HER -2/ neu -overexpressing human breast cancer cells to docetaxel (taxotere).

BREAST CANCER RESEARCH AND TREATMENT, 2004, 84, 183-195 dx.doi.org/10.1023/B:BREA.0000018409.59448.60

Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R

Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.

INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24, 591-608

Fernández-Real JM, Castro A, Vázquez G, Casamitjana R, López-Bermejo A, Peñarroja G, Ricart W

Adiponectin is associated with vascular function independent of insulin sensitivity.

Diabetes Care, 2004, 27, 739-745 dx.doi.org/10.2337/diacare.27.3.739

Garre-Olmo J, López-Pousa S, Vilalta-Franch J, Turon-Estrada A, Lozano-Gallego M, Hernández-Ferràndiz M, Gelada-Batlle E, Cruz-Reina MM, Morante-Muñoz V, Peralta-Rodríguez J

Neuropsychological profile of Alzheimer's disease in women: moderate and moderately severe cognitive decline.

ARCH WOMEN MENT HLTH, 2004, 7, 27-36 dx.doi.org/10.1007/s00737-003-0030-8

López-Bermejo A, Botas P, Funahashi T, Delgado E, Kihara S, Ricart W, Fernández-Real JM

Adiponectin, hepatocellular dysfunction and insulin sensitivity.

CLINICAL ENDOCRINOLOGY, 2004, 60, 256-263 dx.doi.org/10.1046/j.1365-2265.2004.01977.x

Fernández-Real JM, Botas-Cervero P, López-Bermano A, Casamitjana R, Funahashi T, Delgado E, Kihara S, Ricart W

Adiponectin is independently associated with glycosylated haemoglobin.

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150, 201-205 dx.doi.org/10.1530/eje.0.1500201

Castillo J, Leira R, García MM, Serena J, Blanco M, Dávalos A

Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome.

Stroke, 2004, 35, 520-526 dx.doi.org/10.1161/01.STR.0000109769.22917.B0

Coneix l’IDIBGI!

 menu